Previous Article | Next Article ![]()
Journal of Bacteriology, March 2009, p. 1982-1985, Vol. 191, No. 6
0021-9193/09/$08.00+0 doi:10.1128/JB.01012-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
,
Daisuke Nakane, and
Makoto Miyata*
Graduate School of Science, Osaka City University, Sumiyoshi-ku, Osaka 558-8585, Japan
Received 23 July 2008/ Accepted 18 December 2008
|
|
|---|
|
|
|---|
Effects of anti-Gli349 antibodies on binding and gliding. Previously, we isolated a monoclonal antibody (MAb), MAb7, against the leg protein Gli349 and analyzed its effects on mycoplasma gliding (6, 20, 22). In the present study, similar results were obtained (Fig. 1, left panels). MAb7 displaced gliding mycoplasmas from the glass in a concentration-dependent manner and also reduced the gliding speed. A mycoplasma cell generates a maximum force of 27 pN (12), which is 1,800 times larger than the force (15 fN) calculated to be necessary for the normal speed of mycoplasma movement (18). Considering this fact, the additional drag force should be considered. One possible scenario is that a conformation of Gli349 generates the drag force. Here, we isolated a new antibody, MAb33 (20); analyzed its effect on gliding, and found that this antibody displaced the gliding mycoplasmas from the glass without a reduction of speed prior to detachment (Fig. 1, center panels). This observation suggests that the putative drag in the inhibition by MAb7 is caused by Gli349, because other causes are unlikely to depend on the binding sites of anti-Gli349 MAbs.
![]() View larger version (27K): [in a new window] |
FIG. 1. Effects of anti-Gli349 antibodies on glass binding and gliding speed of wild-type cells. The effects on binding and speed are presented in the upper and lower panels, respectively. The antibodies and Fab were added at time zero. The numbers of bound cells in an area 280 µm square and their average gliding speeds are presented relative to the initial values on a logarithmic scale. The gliding speeds were analyzed for three consecutive intervals of 0.333 s by using Image J version 1.33v with the plug-in software MultiTracker ver1 (http://rsb.info.nih.gov/ij/plugins/multitracker.html) and are presented as the average for more than 40 cells on a logarithmic scale when sufficient numbers of cells were on glass. Antibody concentrations in mg/ml are as indicated in the central lower graph.
|
Isolation and characterization of mutants resistant to MAb7. Colonies of M. mobile have the ability to adsorb red blood cells (RBC) (hemadsorption [HA] activity), and this activity was blocked when an RBC suspension was mixed with MAb7 (22). Previously, we isolated an adhesive mutant, the gli521(P476R) mutant, by screening for a colony which can adsorb RBC in the presence of MAb7 (23). Here, we screened about 6,000 colonies for other spontaneous mutants with HA activity resistant to MAb7 and obtained 43 isolates. We sequenced the 30,469-bp DNA region encoding the gliding proteins, as described previously (20, 24), for eight strains and found that all of the mutants have a single nucleotide substitution, resulting in a single amino acid substitution (Table 1). Seven isolates had the same substitution, from serine to arginine at amino acid 859, among the entire 4,727-amino-acid sequence of the gli521 open reading frame. One of them was named the gli521(S859R) mutant and was used for further studies. Another isolate was analyzed and named the gli349(S1362W) mutant.
|
View this table: [in a new window] |
TABLE 1. Antibodies and mutants
|
![]() View larger version (11K): [in a new window] |
FIG. 2. Binding and gliding properties of each strain. (Left) The cell suspension was inserted into a tunnel slide at time zero, and the number of bound cells in an area 280 µm square was counted at various time points. (Right) Speeds were averaged for more than 40 cells and are presented with standard deviations. WT, wild type.
|
Target points of antibody and nonbinding mutants on gliding proteins. We expressed 25 protein fragments of the 3,183-amino-acid Gli349 protein in Escherichia coli cells, performed Western blotting, and determined the binding regions of MAb7 and MAb33 (Table 1).
Previously, we isolated five nonbinding and nongliding mutants, named m9, m12, m13, m23, and m26 (Table 1) (14). Mutants m9, m12, and m13 lack the Gli521, Gli123, and Gli349 proteins, respectively, due to a nonsense mutation in the N-terminal positions of their open reading frames (20, 22, 24). In the present study, we sequenced the 30,469-bp DNA region encoding the gliding proteins and found that the m23 mutant had a substitution and the m26 mutant had a tandem duplication nucleotide sequence, resulting in the insertion of the amino acid sequence RPTA at the C-terminal side of amino acid 1228, alanine. As we sequenced only the 30,469-bp region of the genome, additional mutations in other regions in those mutants cannot be ruled out. However, we assumed that the mutant phenotypes are caused by the mutations identified here, because so far we have sequenced the 30,469-bp DNA region for 14 mutants and found that only the m26 mutant possesses an additional mutation.
Hot spots on Gli349 and Gli521 molecules. The Gli349 protein plausibly plays a role as a leg. In the present study, we mapped the binding points of two inhibitory antibodies and three mutation points affecting gliding on Gli349, and we found that four target points are located in a 301-amino-acid region comprising amino acids 1193 to 1492. Inhibition of gliding by the antibodies suggests that this region should be exposed to the outside, and the conformational changes of this domain are essential for the mechanism. Direct involvement of this region in the gliding mechanism is supported by the isolation of the m26 and gli349(S1362W) mutants. Previously, we assigned the amino acid sequence to the molecular structure of the Gli349 protein (Fig. 3) (1, 7). According to this assumption, the 301-amino-acid region including those four target points is predicted to form a 12-nm part at the proximal end of the leg structure. On the other hand, m23, a binding-defective mutant, has a mutation at amino acid 2770 of Gli349. The C-terminal region has been assigned to the foot in the schematic image, suggesting that the foot is responsible for catching the binding target, sialyllactose. This assumption is consistent with the position of the mutation in the m23 mutant.
![]() View larger version (29K): [in a new window] |
FIG. 3. Antibody binding sites and mutation points shown on a schematic of a Gli349 molecule. The gliding machinery is composed of the Gli123, Gli349, Gli521, and P42 proteins. The molecular shape of Gli349 was suggested from electron microscopy studies to be formed by three rods and one oval "foot," which are tandemly connected by three hinges (1). A transmembrane segment is predicted for amino acids 9 to 31 (22). Repeat sequences of 100 amino acids with weak similarity are shown by ovals as follows: A, 118 to 222; E, 616 to 727; G, 830 to 938; H, 944 to 1047; I, 1048 to 1161; J, 1248 to 1343; K, 1344 to 1449; L, 1450 to 1546; M, 1553 to 1657; N, 1658 to 1762; O, 1765 to 1872; P, 1873 to 1972; Q, 1974 to 2080; R, 2084 to 2191; S, 2286 to 2391; T, 2396 to 2501; U, 2515 to 2608; and V, 2610 to 2720 (7). The binding sites of MAb7 and MAb33, comprised of regions 1193 to 1203 and 1477 to 1492, are shown by closed triangles. The mutation points of m26, the gli349(S1362W) mutant, and m23 at amino acids 1228, 1362, and 2770 are shown by open triangles.
|
Working model. All effects caused by each antibody and mutation can be qualitatively explained by the assignment of these effectors to a single step of our working model (8, 9), as postulated in Fig. S5 in the supplemental material.
This work was supported by a Grant-in-Aid for Scientific Research (A) and a Grant-in-Aid for Scientific Research on the Priority Areas "Applied Genomics" and "Structures of Biological Macromolecular Assemblies" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M.M.) and by a grant from the Institution for Fermentation Osaka (to M.M.).
Published ahead of print on 5 January 2009. ![]()
Supplemental material for this article may be found at http://jb.asm.org/. ![]()
Present address: Department of Infectious Diseases, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»